Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis

Fig. 3

Evaluator’s global assessment of disease activity in relation to dysbiosis index levels. Distribution of Evaluator’s global assessment of disease activity (EvalGlobal; Likert scale 0–4, corresponding to Remission/Low/Medium/High/Maximal) among axSpA patients (nr-axSpA and AS combined) with different levels of dysbiosis index (DI) score 1–5. Number of patients in each group: DI 1 n=51, DI 2 n=33, DI 3 n=35, DI 4, or 5 n=8 (DI 4 and 5 combined into one group due to too few cases). No patients in any DI group were assessed as having high or maximal disease activity. P=0.055 for overall between-group difference by Kruskal-Wallis test. AS ankylosing spondylitis, axSpA axial spondyloarthritis, DI dysbiosis index, nr-axSpA non-radiographic axial spondyloarthritis

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us